• Caption...yes
    At Axis-Shield, innovation is fundamental to our business. There is an increasing need for new diagnostic tests in many disease areas, including those associated with an increasingly ageing population.
  • Identifying these diseases quickly and efficiently, where possible at the point of care, can be vital in maintaining a patient's quality of life.
  • New drug treatments are evolving alongside innovative diagnostics, which is leading to improved patient management and monitoring of treatment efficacy.
  • We are continually striving to develop improved methods to diagnose disease, employing both in-house expertise and our links with external centres of excellence.

Latest News


Learn more about how Afinion CRP is being used as part of the Alere Test Target Treat campaign



Axis-Shield signs a licensing and development deal with Siemens Healthcare for it's proprietary Active-B12 test


Afinion is a new concept
in Point of Care - a multi-parameter rapid analyser system with minimal user input...


Afinion features


Axis-Shield's most widely
distributed product range is particularly suited to countries with developing healthcare systems...


NycoCard features

Laboratory Tests

In the laboratory sector
we specialise in proprietary markers for early diagnosis and management of critical illnesses....

› Tests


Contract development and manufacturing
of OEM products is a core strength of our Laboratory Division.... 


› OEM capabilities

Axis-Shield is an Alere company




© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland.
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.